EUVIMEDEUVIMED entdecken
Crossref

From brain fog to COVID toe: A head-to-toe review of long COVID

Jamie K. Stone, Sarah E. Berman, Wendy Zheng, Drake R. Wilson, Gabrielle R. Diaz

American Journal of Pharmacotherapy and Pharmaceutical Sciences · 2023

DOI: 10.25259/ajpps_2023_012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Pharmacotherapy and Pharmaceutical Sciences, 2023. Verfasst von Jamie K. Stone und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 140 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the World Health Organization’s announcement of the end of the coronavirus disease 2019 (COVID-19) public health emergency, both clinicians and patients may think that the COVID-19 era is over. While the pandemic may have ended, acute infections continue to occur as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus transitions to the endemic phase. After initial COVID-19 infection, approximately 20% of patients experience persistent symptoms for more than 4 weeks. This clinical phenomenon is often termed “long COVID” but many other terms exist in the literature including “Post-COVID-19 syndrome,” “Chronic COVID-19,” “long haul COVID,” “post-acute COVID-19 syndrome,” “long-term sequelae,” and “post-acute sequelae of SARS-CoV-2 infection,” among others. For the purposes of this review, we define long COVID as symptoms occurring more than 4 weeks after initial infection. Long COVID manifests in a wide variety of symptoms, including cough, fatigue, muscle weakness, cognitive impairment, shortness of breath, and chest pain. In fact, current literature indicates that long COVID has effects throughout every major organ system. Within this review, we compile and summarize the available data regarding symptoms of long COVID using a head-to-toe approach. This review is meant to be comprehensive covering the following organ systems: neurologic, cardiac, pulmonary, gastrointestinal, hepatic, renal, genitourinary, hematologic, musculoskeletal, and integumentary. The purpose of this narrative review is to provide a broad and inclusive resource for clinicians on long COVID symptomatology, pathophysiology, and potential treatments.

Zitieren

APA

Stone, J. K., Berman, S. E., Zheng, W., Wilson, D. R., & Diaz, G. R. (2023). From brain fog to COVID toe: A head-to-toe review of long COVID. American Journal of Pharmacotherapy and Pharmaceutical Sciences. https://doi.org/10.25259/ajpps_2023_012

Vancouver

Stone JK, Berman SE, Zheng W, Wilson DR, Diaz GR. From brain fog to COVID toe: A head-to-toe review of long COVID. American Journal of Pharmacotherapy and Pharmaceutical Sciences. 2023. doi:10.25259/ajpps_2023_012

BibTeX
@article{Stone2023,
  author = {Stone, Jamie K. and Berman, Sarah E. and Zheng, Wendy and Wilson, Drake R. and Diaz, Gabrielle R.},
  title = {From brain fog to COVID toe: A head-to-toe review of long COVID},
  journal = {American Journal of Pharmacotherapy and Pharmaceutical Sciences},
  year = {2023},
  doi = {10.25259/ajpps_2023_012}
}
Kostenlos starten →